BIOMAT Database Logo BIOMAT Database Logo

[Ovarian stimulation with gonadotropins: comparison between recombinant FSH plus menotropins versus recombinant FSH + LH]. 2014

Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova

BACKGROUND Nowadays various assisted reproduction ovarian stimulation schemes are used for different clinical outcomes is interesting to compare. OBJECTIVE Compare two ovarian stimulation protocols: recombinant FSH + LH versus recombinant FSH + Menotropins. METHODS Observational, retrospective study, 38 cycles were analyzed, made from 2010 until 2013, assigned to two groups (n = 19 each), group 1 received FSHr + LHr, group 2 received FSHr + menotropins. Study variables were: days of ovarian stimulation, total gonadotropin dose, retrieved oocytes, fertilization rate, pregnancy rate and number of vitrified embryos. RESULTS Fewer stimulation days (8.5 +/- 1.5 vs 9 +/- 1.1) were found in group 1 (recombinant gonadotropins). Group 2 (FSHr + Menotropins), had a greater total dose of gonadotropins (1930.2 +/- 346.2 vs 2000 +/- 418.8) and more retrieved oocytes (8.15 +/- 3.9 vs 8.57 +/- 4). Group 1 patients had higher pregnancy and fertilization rates (56.2 vs 36.8%, and 75.4 vs 69.3%) respectively, no statistical significance was found. CONCLUSIONS This study found higher pregnancy and fertilization rates in patients treated with recombinant gonadotropins (FSH + LH) for ovarian stimulation.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008596 Menotropins Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations. Gonadotropins, Human Menopausal,Human Menopausal Gonadotropin,CP-89044,CP-90033,HMG Ferring,HMG Lepori,HMG Massone,Humegon,Menogon,Menopur,Menotrophin,Normegon,ORG-31338,Pergonal,Pergonal-500,CP 89044,CP 90033,CP89044,CP90033,Gonadotropin, Human Menopausal,Human Menopausal Gonadotropins,Lepori, HMG,Menopausal Gonadotropin, Human,ORG 31338,ORG31338,Pergonal 500,Pergonal500
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006062 Gonadotropins Hormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis (GONADOTROPINS, PITUITARY) and the placenta (CHORIONIC GONADOTROPIN). In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities. Gonadotropin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter?
December 2019, Reproductive biomedicine online,
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
December 2021, Reproductive biology and endocrinology : RB&E,
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
[Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
February 1997, Contraception, fertilite, sexualite (1992),
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF.
July 2018, Reproductive biology and endocrinology : RB&E,
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. II. Comparison of hMG and recombinant FSH.
January 1997, International journal of fertility and women's medicine,
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
FSH and LH together in ovarian stimulation.
July 2004, European journal of obstetrics, gynecology, and reproductive biology,
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH.
July 2000, Human reproduction (Oxford, England),
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction.
May 2000, Human reproduction (Oxford, England),
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
Recombinant LH in ovarian stimulation.
June 2005, Reproductive biomedicine online,
Alvaro Santibáñez Morales, and Edgar Omar Colín Licea, and Esteban Durán Boullosa, and Paola Sánchez Serrano, and Olga Pashkova
Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT.
July 2017, International journal of reproductive biomedicine,
Copied contents to your clipboard!